Literature DB >> 2128382

Glycated haemoglobin and fructosamine in non-diabetic subjects with chronic renal failure.

L J Morgan1, C B Marenah, A G Morgan, R P Burden, W G John.   

Abstract

Measurements of glycated haemoglobin by electroendosmotic and chromatographic methods, fructosamine, and fructosamine:albumin ratio were made in 91 non-diabetic subjects with chronic renal failure managed conservatively (n = 25), by continuous ambulatory peritoneal dialysis (n = 22), by haemodialysis (n = 22), or by renal transplantation (n = 22). Results were compared with those in a control group of 43 non-diabetic subjects with normal renal function. Mean glycated haemoglobin measured by electroendosmosis was significantly greater in all groups with chronic renal failure except the transplant group. Mean glycated haemoglobin measured by affinity chromatography was not significantly different from controls in any of the groups with chronic renal failure. No difference in mean fructosamine concentration was detected in the transplant or conservatively managed groups compared to controls, but values were significantly lower in the CAPD group, and greater in the haemodialysis group predialysis. Post-haemodialysis samples showed a significant reduction in mean fructosamine concentration when compared with prehaemodialysis samples. Fructosamine:albumin ratios were elevated in all groups of patients with renal failure, with the exception of the transplant group. Of the four indices of glycaemic control considered in this study, only glycated haemoglobin measured by affinity chromatography appears to be unaffected by chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2128382     DOI: 10.1093/ndt/5.10.868

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

1.  Hemoglobin A1c levels in non-diabetic patients with end-stage renal disease (ESRD) receiving hemodialysis.

Authors:  X Wang; S K Peesapati; M F Renedo; S Moktan
Journal:  J Endocrinol Invest       Date:  2004-09       Impact factor: 4.256

Review 2.  The diagnosis of posttransplantation diabetes mellitus: meeting the challenges.

Authors:  J Werzowa; M Hecking; M Haidinger; D Döller; A Sharif; A Tura; M D Säemann
Journal:  Curr Diab Rep       Date:  2015-05       Impact factor: 4.810

3.  Measurement of Hba(1C) in patients with chronic renal failure.

Authors:  Randie R Little; Curt L Rohlfing; Alethea L Tennill; Steven E Hanson; Shawn Connolly; Trefor Higgins; Charles E Wiedmeyer; Cas W Weykamp; Richard Krause; William Roberts
Journal:  Clin Chim Acta       Date:  2013-01-12       Impact factor: 3.786

4.  Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus.

Authors:  Kamyar Kalantar-Zadeh; Stephen F Derose; Susan Nicholas; Deborah Benner; Kumar Sharma; Csaba P Kovesdy
Journal:  J Ren Nutr       Date:  2009-01       Impact factor: 3.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.